New Horizon Aircraft Secures $19.9M in Dilutive Offering to Fund Cavorite X7 Development

summarizeSummary

New Horizon Aircraft Ltd. has entered into definitive agreements for a registered direct offering, raising approximately $19.9 million through the sale of 9.25 million shares at $2.15 each, crucial for funding its Cavorite X7 aircraft program and addressing prior going concern doubts.

check_boxKey Events

• Secures $19.9 Million in Capital

  New Horizon Aircraft Ltd. entered into Securities Purchase Agreements with institutional investors for a registered direct offering, generating approximately $19.9 million in gross proceeds.

• Issuance of New Shares

  The company will issue an aggregate of 9,254,889 Class A ordinary shares at an offering price of $2.15 per share. The closing is expected on or about May 8, 2026.

• Significant Dilution Impact

  The issuance of 9,254,889 shares represents an immediate dilution of approximately 19.86% of the company's currently outstanding shares. Additionally, warrants to purchase 277,647 shares were issued to the placement agent, potentially increasing total dilution to approximately 20.45%.

• Funding for Cavorite X7 Program

  Net proceeds from the offering are intended to fund and accelerate the development and buildout of the Cavorite X7 aircraft program, as well as for general working capital and corporate purposes.

auto_awesomeAnalysis

This 8-K filing formalizes the definitive agreements for a registered direct offering, which was previously announced in news. The company is raising approximately $19.9 million by issuing 9,254,889 Class A ordinary shares at $2.15 per share. This capital raise is critical for New Horizon Aircraft, especially given its previously disclosed significant net loss and persistent going concern doubt. The proceeds are earmarked to accelerate the development of its Cavorite X7 aircraft program, as well as for general working capital. While the offering is highly dilutive, representing an immediate dilution of approximately 19.86% of outstanding shares (with potential for further dilution from placement agent warrants), it provides essential funding to extend the company's operational runway and advance its core product development. The offering price of $2.15 per share is at a slight discount to the current market price of $2.29.